Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

Fig. 2

Molecular genotypes and radioactive iodine therapy. a Molecular genotypes of 30 well-differentiated thyroid carcinomas with distant metastases based on TERT promoter mutations and BRAF V600E. b Structural response of distant metastatic disease to radioactive iodine therapy classified by molecular genotypes in 30 well-differentiated thyroid carcinoma patients with distant metastasis. PTC, papillary thyroid carcinoma; TCF, tall cell features; FTC, follicular thyroid carcinoma; TERT, TERT promoter mutations; BRAF, BRAF V600E; (+), mutation positive; (-), mutation negative

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us